Co SE (KCO:GR) with a Buy rating and a price target of EUR8.10. The firm's analysts highlight the company's strategic shift towards more promising opportunities in North America and the ...

Kepler Cheuvreux adjusted its stance on Signify NV (LIGHT:NV) (OTC: SFFYF), downgrading the company's stock rating from Hold to Reduce. Accompanying this downgrade, the firm also reduced Signify's ...

Kepler Cheuvreux downgraded Signify (SFFYF) to Reduce from Hold with a price target of EUR 18, down from EUR 25. The firm cites the company’s ...

Kepler Cheuvreux downgraded Umicore (UMICY) to Hold from Buy with a price target of EUR 10.50, down from EUR 18. The firm sees the company’s ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with MASH and other diseases with ...

Daix (France), New York City (New York, United States), January 24, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company ...

While the report is intended as an informative resource, Kepler Partners LLP discloses that it has a relationship with the company covered in the report, which may affect the objectivity of the ...

Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with MASH and other diseases with ...